KARL V. KITZMILLER, M.D., F.A.C.P.
This content is PDF only. Please click on the PDF icon to access.
The increasing prevalence in the use of Pasteurella tularensis antiserum, which recently has become commercially available, in the treatment of tularemia, makes the report of a fatal case in which the antiserum was used of special interest at this time. Particularly so, when the fatality is sudden and unexpected, following the antiserum treatment by only a few days. Foshay has stated that in his experience in the specific treatment of these cases he knows of none, with the exception of the advanced, overwhelming infections, in which some associated lesion usually involving the circulatory system has not been responsible for the
KITZMILLER KV. TULAREMIA; A PATHOLOGIC STUDY OF THE LESIONS IN A CASE TREATED WITH SPECIFIC ANTISERUM, THE PATIENT DYING SUDDENLY FROM INTERCURRENT CORONARY OCCLUSION1. Ann Intern Med. ;12:1375–1381. doi: 10.7326/0003-4819-12-8-1375
Download citation file:
Published: Ann Intern Med. 1939;12(8):1375-1381.
Bioterrorism Infectious Agents, Cardiology, Coronary Heart Disease, Infectious Disease, Tick-Borne Diseases.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use